Академический Документы
Профессиональный Документы
Культура Документы
Schedules of Drugs & Cosmetics Act from A to Y with their short description used in Indian
pharmaceutical manufacturing.
Ankur Choudhary | Regulatory | Print | Question ForumBe the first to comment!
Indian pharmaceutical GMP guidelines are given in Drugs & Cosmetics Act 1940. Rules are
given for pharmaceuticals and schedules are there to comply those rules.
MINISTRY OF HEALTH AND FAMILY WELFARE (Department of Health) updates this time
to time. Pharmaceutical industries in India those are manufacturing the drug products
for domestic market have to follow the Drugs & Cosmetics Act.
It contains 168 rules from 1 to 168 and 25 Schedules from Schedule A to Schedule Y.
Different type of forms are also given for different type of approvals from drug authorities.
Following are the schedules:
Schedule A: Forms and applications
Schedule B: Fees for test or analysis by the Central Drugs Laboratories or State Drugs
Laboratories
Schedule C: Biological and Special Products
Schedule C(1): Other Special Products
Schedule D: Class of Drugs: Extent and conditions of exemption
Schedule D(I): Information and undertaking required to be submitted by the manufacturer of his
authorized agent with the application form for a Registration Certificate. The format shall be
properly filled in for each application in Form 40. The detailed information, secret in nature, may
be furnished on a computer floppy.
Schedule D(II): Information required to be submitted by the manufacturer or his authorized
agent with the application form for the registration of a bulk drug/formulation/special product for
its import into India. The format shall be properly filled in and the detailed information, secret in
nature, may be furnished on a computer floppy.
Schedule E: Omitted
Schedule E(1): List of Poisonous Substances under the Ayurvedic (including Siddha) and Unani
Systems of Medicine
Schedule F: Part I to Part XII-A Omitted
Part XII-B: Requirements for the functioning and operation of a Blood Bank and / or for
preparation of Blood Components
Part I-C: Specific requirement for manufacture of oral liquids (Syrups, elixirs, emulsions and
suspensions).
Part I-D: Specific requirements for manufacture of topical products i.e. external preparation
(creams, ointments, pastes, emulsions, lotions, solutions, dusting powders and identical
products)
Part I-E: Specific requirements for manufacture of metered-dose-inhalers (MDI)
Part I-F: Specific requirements of premises, plant and materials for manufacture of active
pharmaceutical ingredients ( Bulk Drugs ).
Part II: Requirements of plant and equipment.
Schedule M-I: 1. Requirements of factory premises for manufacture of homoeopathic
preparations.
2. Requirements of plants and equipments.
Schedule M-II: Requirements of factory premises for manufacture of cosmetic.
Schedule M-III: Requirements of factory premises for manufacture of medical devices.
Part I-B: Specific requirement for manufacturing of oral solid dosage forms (Tablet and
Capsules).
Part I-C: Specific requirement for manufacture of oral liquids ( Syrup, elixirs, emulsions and
suspensions).
Part I-D: Specific requirements for manufacture of topical products i.e. external preparation (
creams, ointments, pastes, emulsions, lotions, solutions, dusting powders and identical products )
Part I-E: Specific requirements for manufacture of metered-dose-inhalers (MDI)
Part I-F: Specific requirements of premises, plant and materials for manufacture of active
pharmaceutical ingredients ( Bulk Drugs ).
Part II: Requirements of plant and equipment.
Schedule N: List of Minimum Equipment for the Efficient Running of a Pharmacy
Schedule O: Standard for Disinfectant Fluids
Schedule P: Life Period of Drugs
Schedule P1: Pack Sizes of Drugs
Schedule Q: List of Dyes, colours and Pigments permitted to be used in Cosmetics and Soaps as
given under IS : 4707 (Part I)-1988 as amended by the Bureau of Indian Standards
Schedule R: Standards for condoms made of rubber latex intended for single use and other
mechanical contraceptives
undertake clinical Trials.